{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:14:10Z","timestamp":1760645650525},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Influenza epidemics continue to cause morbidity and mortality within the human population despite widespread vaccination efforts. This, along with the ominous threat of an avian influenza pandemic (H5N1), demonstrates the need for a much improved, more sophisticated influenza vaccine. We have developed an in vitro model system for producing a membrane-bound Cytokine-bearing Influenza Vaccine (CYT-IVAC). Numerous cytokines are involved in directing both innate and adaptive immunity and it is our goal to utilize the properties of individual cytokines and other immunomodulatory proteins to create a more immunogenic vaccine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We have evaluated the immunogenicity of inactivated cytokine-bearing influenza vaccines using a mouse model of lethal influenza virus challenge. CYT-IVACs were produced by stably transfecting MDCK cell lines with mouse-derived cytokines (GM-CSF, IL-2 and IL-4) fused to the membrane-anchoring domain of the viral hemagglutinin. Influenza virus replication in these cell lines resulted in the uptake of the bioactive membrane-bound cytokines during virus budding and release.<jats:italic>In vivo<\/jats:italic>efficacy studies revealed that a single low dose of IL-2 or IL-4-bearing CYT-IVAC is superior at providing protection against lethal influenza challenge in a mouse model and provides a more balanced Th<jats:sub>1<\/jats:sub>\/Th<jats:sub>2<\/jats:sub>humoral immune response, similar to live virus infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have validated the protective efficacy of CYT-IVACs in a mammalian model of influenza virus infection. This technology has broad applications in current influenza virus vaccine development and may prove particularly useful in boosting immune responses in the elderly, where current vaccines are minimally effective.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-6-42","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T18:29:39Z","timestamp":1240597779000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge"],"prefix":"10.1186","volume":"6","author":[{"given":"Andrew S","family":"Herbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Sundick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"556_CR1","unstructured":"Update: influenza activity \u2013 United States and worldwide, 2005\u201306 season, and composition of the 2006\u201307 influenza vaccine MMWR Morb Mortal Wkly Rep 2006, 55: 648-653."},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1128\/CMR.14.1.129-149.2001","volume":"14","author":"T Horimoto","year":"2001","unstructured":"Horimoto T, Kawaoka Y: Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 2001, 14: 129-149. 10.1128\/CMR.14.1.129-149.2001","journal-title":"Clin Microbiol Rev"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(04)15595-5","volume":"363","author":"JS Peiris","year":"2004","unstructured":"Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363: 617-619. 10.1016\/S0140-6736(04)15595-5","journal-title":"Lancet"},{"key":"556_CR4","unstructured":"Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection Wkly Epidemiol Rec 2006, 81: 249-257."},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa044021","volume":"352","author":"K Ungchusak","year":"2005","unstructured":"Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S: Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352: 333-340. 10.1056\/NEJMoa044021","journal-title":"N Engl J Med"},{"key":"556_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.biopha.2004.04.009","volume":"58","author":"Y Kuroda","year":"2004","unstructured":"Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M: Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 2004, 58: 325-337. 10.1016\/j.biopha.2004.04.009","journal-title":"Biomed Pharmacother"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/515285","volume":"177","author":"S Sambhara","year":"1998","unstructured":"Sambhara S, Woods S, Arpino R, Kurichh A, Tamane A, Underdown B, Klein M, Lovgren Bengtsson K, Morein B, Burt D: Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes. J Infect Dis 1998, 177: 1266-1274.","journal-title":"J Infect Dis"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/cimm.2001.1835","volume":"211","author":"S Sambhara","year":"2001","unstructured":"Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D: Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 2001, 211: 143-153. 10.1006\/cimm.2001.1835","journal-title":"Cell Immunol"},{"key":"556_CR9","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.153.9.4029","volume":"153","author":"JP Valensi","year":"1994","unstructured":"Valensi JP, Carlson JR, Van Nest GA: Systemic cytokine profiles in BALB\/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J Immunol 1994, 153: 4029-4039.","journal-title":"J Immunol"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","volume":"370","author":"I Leroux-Roels","year":"2007","unstructured":"Leroux-Roels I, Borkowski A, Vanwolleghem T, Drame M, Clement F, Hons E, Devaster JM, Leroux-Roels G: Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007, 370: 580-589. 10.1016\/S0140-6736(07)61297-5","journal-title":"Lancet"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1128\/JVI.77.6.3615-3623.2003","volume":"77","author":"SM Kang","year":"2003","unstructured":"Kang SM, Compans RW: Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus. J Virol 2003, 77: 3615-3623. 10.1128\/JVI.77.6.3615-3623.2003","journal-title":"J Virol"},{"key":"556_CR12","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.159.7.3638","volume":"159","author":"E Okada","year":"1997","unstructured":"Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K: Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 1997, 159: 3638-3647.","journal-title":"J Immunol"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0264-410X(98)00223-0","volume":"17","author":"SW Lee","year":"1999","unstructured":"Lee SW, Youn JW, Seong BL, Sung YC: IL-6 induces long-term protective immunity against a lethal challenge of influenza virus. Vaccine 1999, 17: 490-496. 10.1016\/S0264-410X(98)00223-0","journal-title":"Vaccine"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0264-410X(98)00347-8","volume":"17","author":"I Babai","year":"1999","unstructured":"Babai I, Samira S, Barenholz Y, Zakay-Rones Z, Kedar E: A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin\/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. Vaccine 1999, 17: 1239-1250. 10.1016\/S0264-410X(98)00347-8","journal-title":"Vaccine"},{"key":"556_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.1994.50.33","volume":"50","author":"B Golding","year":"1994","unstructured":"Golding B, Zaitseva M, Golding H: The potential for recruiting immune responses toward type 1 or type 2 T cell help. Am J Trop Med Hyg 1994, 50: 33-40.","journal-title":"Am J Trop Med Hyg"},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ijc.11612","volume":"108","author":"HI Huang","year":"2004","unstructured":"Huang HI, Wu PY, Teo CY, Chen MN, Chen YC, Silin D, Tao MH: Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand. Int J Cancer 2004, 108: 696-703. 10.1002\/ijc.11612","journal-title":"Int J Cancer"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.virol.2004.06.047","volume":"328","author":"YK Oh","year":"2004","unstructured":"Oh YK, Sohn T, Park JS, Kang MJ, Choi HG, Kim JA, Kim WK, Ko JJ, Kim CK: Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant. Virology 2004, 328: 266-273. 10.1016\/j.virol.2004.06.047","journal-title":"Virology"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00002371-200301000-00007","volume":"26","author":"P Nizard","year":"2003","unstructured":"Nizard P, Gross DA, Babon A, Chenal A, Beaumelle B, Kosmatopoulos K, Gillet D: Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice. J Immunother 2003, 26: 63-71. 10.1097\/00002371-200301000-00007","journal-title":"J Immunother"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0264-410X(98)00346-6","volume":"17","author":"I Babai","year":"1999","unstructured":"Babai I, Samira S, Barenholz Y, Zakay-Rones Z, Kedar E: A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin\/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine 1999, 17: 1223-1238. 10.1016\/S0264-410X(98)00346-6","journal-title":"Vaccine"},{"key":"556_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/intimm\/13.6.713","volume":"13","author":"L Faulkner","year":"2001","unstructured":"Faulkner L, Buchan G, Lockhart E, Slobbe L, Wilson M, Baird M: IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. Int Immunol 2001, 13: 713-721. 10.1093\/intimm\/13.6.713","journal-title":"Int Immunol"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/sj.gt.3301803","volume":"9","author":"S Yei","year":"2002","unstructured":"Yei S, Bartholomew RM, Pezzoli P, Gutierrez A, Gouveia E, Bassett D, Soo Hoo W, Carlo DJ: Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine. Gene Ther 2002, 9: 1302-1311. 10.1038\/sj.gt.3301803","journal-title":"Gene Ther"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/jir.2008.0017","volume":"29","author":"Y Yang","year":"2009","unstructured":"Yang Y, Leggat D, Herbert A, Roberts PC, Sundick RS: A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles. J Interferon Cytokine Res 2009, 29: 9-22. 10.1089\/jir.2008.0017","journal-title":"J Interferon Cytokine Res"},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1099\/00221287-10-3-457","volume":"10","author":"HB Donald","year":"1954","unstructured":"Donald HB, Isaacs A: Counts of influenza virus particles. J Gen Microbiol 1954, 10: 457-464.","journal-title":"J Gen Microbiol"},{"key":"556_CR24","first-page":"1178","volume":"26","author":"ND Lawson","year":"1998","unstructured":"Lawson ND, Krause DS, Berliner N: Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines. Exp Hematol 1998, 26: 1178-1185.","journal-title":"Exp Hematol"},{"key":"556_CR25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.142.3.800","volume":"142","author":"J Hu-Li","year":"1989","unstructured":"Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE: Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 1989, 142: 800-807.","journal-title":"J Immunol"},{"key":"556_CR26","first-page":"1","volume-title":"WHO Manual on Animal Influenza Diagnosis and Surveillance","author":"RG Webster","year":"2002","unstructured":"Webster RG, Cox N, Stohr K: WHO Manual on Animal Influenza Diagnosis and Surveillance. World Health Organization, Department of Communicable Disease Surveillance and Response; WHO\/CDS\/CDR\/2002.5 Rev.; 2002:1."},{"key":"556_CR27","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H: A Simple Method of Estimating Fifty Percent End Points. Am J Hyg 1938, 27: 493-497.","journal-title":"Am J Hyg"},{"key":"556_CR28","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1128\/IAI.01943-06","volume":"75","author":"JL Speshock","year":"2007","unstructured":"Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC: Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 2007, 75: 3102-3111. 10.1128\/IAI.01943-06","journal-title":"Infect Immun"},{"key":"556_CR29","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1073\/pnas.95.10.5746","volume":"95","author":"PC Roberts","year":"1998","unstructured":"Roberts PC, Compans RW: Host cell dependence of viral morphology. Proc Natl Acad Sci USA 1998, 95: 5746-5751. 10.1073\/pnas.95.10.5746","journal-title":"Proc Natl Acad Sci USA"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/viro.1997.8916","volume":"240","author":"PC Roberts","year":"1998","unstructured":"Roberts PC, Lamb RA, Compans RW: The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 1998, 240: 127-137. 10.1006\/viro.1997.8916","journal-title":"Virology"},{"key":"556_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","volume":"170","author":"SA Ahmed","year":"1994","unstructured":"Ahmed SA, Gogal RM Jr, Walsh JE: A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994, 170: 211-224. 10.1016\/0022-1759(94)90396-4","journal-title":"J Immunol Methods"},{"key":"556_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","volume":"59","author":"RJ Cox","year":"2004","unstructured":"Cox RJ, Brokstad KA, Ogra P: Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004, 59: 1-15. 10.1111\/j.0300-9475.2004.01382.x","journal-title":"Scand J Immunol"},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","volume":"20","author":"WE Beyer","year":"2002","unstructured":"Beyer WE, Palache AM, de Jong JC, Osterhaus AD: Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002, 20: 1340-1353. 10.1016\/S0264-410X(01)00471-6","journal-title":"Vaccine"},{"key":"556_CR34","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1073\/pnas.0400937101","volume":"101","author":"JM Lund","year":"2004","unstructured":"Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004, 101: 5598-5603. 10.1073\/pnas.0400937101","journal-title":"Proc Natl Acad Sci USA"},{"key":"556_CR35","first-page":"107","volume":"146","author":"BR Murphy","year":"1989","unstructured":"Murphy BR, Clements ML: The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989, 146: 107-116.","journal-title":"Curr Top Microbiol Immunol"},{"key":"556_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"CW Potter","year":"1979","unstructured":"Potter CW, Oxford JS: Determinants of immunity to influenza infection in man. Br Med Bull 1979, 35: 69-75.","journal-title":"Br Med Bull"},{"key":"556_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0264-410X(00)00171-7","volume":"19","author":"TG Boyce","year":"2000","unstructured":"Boyce TG, Hsu HH, Sannella EC, Coleman-Dockery SD, Baylis E, Zhu Y, Barchfeld G, DiFrancesco A, Paranandi M, Culley B, Neuzil KM, Wright PF: Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine 2000, 19: 217-226. 10.1016\/S0264-410X(00)00171-7","journal-title":"Vaccine"},{"key":"556_CR38","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303: 1526-1529. 10.1126\/science.1093620","journal-title":"Science"},{"key":"556_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/infdis\/171.1.198","volume":"171","author":"KA Brokstad","year":"1995","unstructured":"Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR: Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis 1995, 171: 198-203.","journal-title":"J Infect Dis"},{"key":"556_CR40","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0264-410X(94)90334-4","volume":"12","author":"RJ Cox","year":"1994","unstructured":"Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS: An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994, 12: 993-999. 10.1016\/0264-410X(94)90334-4","journal-title":"Vaccine"},{"key":"556_CR41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1086\/315003","volume":"180","author":"AS El-Madhun","year":"1999","unstructured":"El-Madhun AS, Cox RJ, Haaheim LR: The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J Infect Dis 1999, 180: 1356-1360. 10.1086\/315003","journal-title":"J Infect Dis"},{"key":"556_CR42","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1086\/515656","volume":"178","author":"AS el-Madhun","year":"1998","unstructured":"el-Madhun AS, Cox RJ, Soreide A, Olofsson J, Haaheim LR: Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J Infect Dis 1998, 178: 933-939. 10.1086\/515656","journal-title":"J Infect Dis"},{"key":"556_CR43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","volume":"236","author":"CM Snapper","year":"1987","unstructured":"Snapper CM, Paul WE: Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987, 236: 944-947. 10.1126\/science.3107127","journal-title":"Science"},{"key":"556_CR44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1086\/314996","volume":"180","author":"BP Arulanandam","year":"1999","unstructured":"Arulanandam BP, O'Toole M, Metzger DW: Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis 1999, 180: 940-949. 10.1086\/314996","journal-title":"J Infect Dis"},{"key":"556_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","volume":"62","author":"AO Hovden","year":"2005","unstructured":"Hovden AO, Cox RJ, Haaheim LR: Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice. Scand J Immunol 2005, 62: 36-44. 10.1111\/j.1365-3083.2005.01633.x","journal-title":"Scand J Immunol"},{"key":"556_CR46","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","volume":"166","author":"VC Huber","year":"2001","unstructured":"Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW: Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 2001, 166: 7381-7388.","journal-title":"J Immunol"},{"key":"556_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/314952","volume":"180","author":"TM Moran","year":"1999","unstructured":"Moran TM, Park H, Fernandez-Sesma A, Schulman JL: Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 1999, 180: 579-585. 10.1086\/314952","journal-title":"J Infect Dis"},{"key":"556_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-065X.1997.tb01009.x","volume":"159","author":"W Gerhard","year":"1997","unstructured":"Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K: Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 1997, 159: 95-103. 10.1111\/j.1600-065X.1997.tb01009.x","journal-title":"Immunol Rev"},{"key":"556_CR49","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1128\/jvi.71.6.4347-4355.1997","volume":"71","author":"K Mozdzanowska","year":"1997","unstructured":"Mozdzanowska K, Furchner M, Washko G, Mozdzanowski J, Gerhard W: A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol 1997, 71: 4347-4355.","journal-title":"J Virol"},{"key":"556_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/CVI.00156-06","volume":"13","author":"VC Huber","year":"2006","unstructured":"Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, Macdonald GH, McCullers JA: Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006, 13: 981-990. 10.1128\/CVI.00156-06","journal-title":"Clin Vaccine Immunol"},{"key":"556_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/383787a0","volume":"383","author":"AK Abbas","year":"1996","unstructured":"Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383: 787-793. 10.1038\/383787a0","journal-title":"Nature"},{"key":"556_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1385\/IR:23:2-3:179","volume":"23","author":"M Boothby","year":"2001","unstructured":"Boothby M, Mora AL, Aronica MA, Youn J, Sheller JR, Goenka S, Stephenson L: IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol Res 2001, 23: 179-191. 10.1385\/IR:23:2-3:179","journal-title":"Immunol Res"},{"key":"556_CR53","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/eji.1830220723","volume":"22","author":"G Siebenkotten","year":"1992","unstructured":"Siebenkotten G, Esser C, Wabl M, Radbruch A: The murine IgG1\/IgE class switch program. Eur J Immunol 1992, 22: 1827-1834. 10.1002\/eji.1830220723","journal-title":"Eur J Immunol"},{"key":"556_CR54","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.4049\/jimmunol.165.4.1877","volume":"165","author":"P Kalinski","year":"2000","unstructured":"Kalinski P, Smits HH, Schuitemaker JH, Vieira PL, van Eijk M, de Jong EC, Wierenga EA, Kapsenberg ML: IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J Immunol 2000, 165: 1877-1881.","journal-title":"J Immunol"},{"key":"556_CR55","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.vaccine.2003.09.023","volume":"22","author":"R Chakrabarti","year":"2004","unstructured":"Chakrabarti R, Chang Y, Song K, Prud'homme GJ: Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA). Vaccine 2004, 22: 1199-1205. 10.1016\/j.vaccine.2003.09.023","journal-title":"Vaccine"},{"key":"556_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.192.6.823","volume":"192","author":"H Hochrein","year":"2000","unstructured":"Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, Shortman K: Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 2000, 192: 823-833. 10.1084\/jem.192.6.823","journal-title":"J Exp Med"},{"key":"556_CR57","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1084\/jem.20050324","volume":"201","author":"Y Yao","year":"2005","unstructured":"Yao Y, Li W, Kaplan MH, Chang CH: Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 2005, 201: 1899-1903. 10.1084\/jem.20050324","journal-title":"J Exp Med"},{"key":"556_CR58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.166.1.633","volume":"166","author":"S Ebner","year":"2001","unstructured":"Ebner S, Ratzinger G, Krosbacher B, Schmuth M, Weiss A, Reider D, Kroczek RA, Herold M, Heufler C, Fritsch P, Romani N: Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol 2001, 166: 633-641.","journal-title":"J Immunol"},{"key":"556_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/annonc\/mdl158","volume":"18","author":"G Parmiani","year":"2007","unstructured":"Parmiani G, Castelli C, Pilla L, Santinami M, Colombo MP, Rivoltini L: Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann Oncol 2007, 18: 226-232. 10.1093\/annonc\/mdl158","journal-title":"Ann Oncol"},{"key":"556_CR60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<663::AID-IJC9>3.0.CO;2-V","volume":"73","author":"T Garrity","year":"1997","unstructured":"Garrity T, Pandit R, Wright MA, Benefield J, Keni S, Young MR: Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 1997, 73: 663-669. 10.1002\/(SICI)1097-0215(19971127)73:5<663::AID-IJC9>3.0.CO;2-V","journal-title":"Int J Cancer"},{"key":"556_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","volume":"103","author":"N Hehme","year":"2004","unstructured":"Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R: Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Virus Res 2004, 103: 163-171. 10.1016\/j.virusres.2004.02.029","journal-title":"Virus Res"},{"key":"556_CR62","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/S0264-410X(03)00078-1","volume":"21","author":"R Ito","year":"2003","unstructured":"Ito R, Ozaki YA, Yoshikawa T, Hasegawa H, Sato Y, Suzuki Y, Inoue R, Morishima T, Kondo N, Sata T, Kurata T, Tamura S: Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. Vaccine 2003, 21: 2362-2371. 10.1016\/S0264-410X(03)00078-1","journal-title":"Vaccine"},{"key":"556_CR63","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/S0264-410X(00)00055-4","volume":"18","author":"K Matsuo","year":"2000","unstructured":"Matsuo K, Yoshikawa T, Asanuma H, Iwasaki T, Hagiwara Y, Chen Z, Kadowaki SE, Tsujimoto H, Kurata T, Tamura SI: Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine 2000, 18: 2713-2722. 10.1016\/S0264-410X(00)00055-4","journal-title":"Vaccine"},{"key":"556_CR64","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","volume":"350","author":"M Mutsch","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350: 896-903. 10.1056\/NEJMoa030595","journal-title":"N Engl J Med"},{"key":"556_CR65","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0264-410X(02)00401-2","volume":"21","author":"S Squarcione","year":"2003","unstructured":"Squarcione S, Sgricia S, Biasio LR, Perinetti E: Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Vaccine 2003, 21: 1268-1274. 10.1016\/S0264-410X(02)00401-2","journal-title":"Vaccine"},{"key":"556_CR66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.149.3.981","volume":"149","author":"S Tamura","year":"1992","unstructured":"Tamura S, Ito Y, Asanuma H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T: Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 1992, 149: 981-988.","journal-title":"J Immunol"},{"key":"556_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0264-410X(88)90140-5","volume":"6","author":"S Tamura","year":"1988","unstructured":"Tamura S, Samegai Y, Kurata H, Nagamine T, Aizawa C, Kurata T: Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6: 409-413. 10.1016\/0264-410X(88)90140-5","journal-title":"Vaccine"},{"key":"556_CR68","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0264-410X(94)90118-X","volume":"12","author":"S Tamura","year":"1994","unstructured":"Tamura S, Yamanaka A, Shimohara M, Tomita T, Komase K, Tsuda Y, Suzuki Y, Nagamine T, Kawahara K, Danbara H, et al.: Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12: 419-426. 10.1016\/0264-410X(94)90118-X","journal-title":"Vaccine"},{"key":"556_CR69","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/eji.1830220228","volume":"22","author":"SI Tamura","year":"1992","unstructured":"Tamura SI, Asanuma H, Ito Y, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T, Oya A: Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 1992, 22: 477-481. 10.1002\/eji.1830220228","journal-title":"Eur J Immunol"},{"key":"556_CR70","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.1128\/JVI.01076-08","volume":"82","author":"BZ Wang","year":"2008","unstructured":"Wang BZ, Quan FS, Kang SM, Bozja J, Skountzou I, Compans RW: Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. J Virol 2008, 82: 11813-11823. 10.1128\/JVI.01076-08","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-6-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:37:20Z","timestamp":1710283040000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-6-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,24]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-6-42","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,24]]},"assertion":[{"value":"10 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42"}}